06 Nov 2026, 06:42 IST
Apollo Hospitals Enterprise Limited
HDFC Securities · BUY · target INR9,990
The report says Apollo's EBITDA grew 29% YoY across hospitals, HealthCo and AHLL segments, and raises concerns on trade margin impact on oncology while retaining BUY with revised TP INR9,990.
From HSIE Results Daily 06 Nov 26 HSIE, written by HDFC Securities. Orivam summarised it; the view is HDFC Securities's, not Orivam's.
Open the original PDF →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.